when will eli lilly release retatrutide Phase 3 obesity trial results 2026 Eli Lilly's Next Weight-Loss Drug

White participants comprised 43.4% of cases and 46.3% of controls, and Black participants 27.3% and 25.4%, respectively

Afamelanotide received EMA approval in Europe (2014) and FDA approval in the United States (2019) for EPP making it the only melanocortin peptide to reach full regulatory approval to date

The Science of Satiety: How GLP-1 and GIP Change the Weight Loss Game GLP-1 (Glucagon-Like Peptide-1): Stimulation of Insulin Release: GLP-1 enhances insulin secretion from pancreatic beta cells

GLP-1 receptor agonist doses are typically escalated gradually with reviews to assess tolerability

State Lyophilized (powder) Storage -4F (-20C) long-term Notes Per supplier safety data sheets, the lyophilized peptide is stable for one year or more under freezer storage

Because Foundayo is a pill, it removes the injection barrier that stops some patients from trying GLP-1 therapy